Skip to main content
VCbacked
Log inGet Started

Seneca Therapeutics

Blue Bell, United States

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

$3.9M raised
Aug 2025
Series B
BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical

Top Investors

Keiretsu CapitalBroad Street AngelsMid Atlantic Bio AngelsK4 Forum Mumbai Network

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Seneca Therapeutics

How much funding has Seneca Therapeutics raised?
Seneca Therapeutics has raised $3.9M in total funding. The most recent round was Series B. The last funding was announced in August 2025.
Who are Seneca Therapeutics's investors?
Seneca Therapeutics's investors include Keiretsu Capital, Broad Street Angels, Mid Atlantic Bio Angels, K4 Forum Mumbai Network.
Where is Seneca Therapeutics headquartered?
Seneca Therapeutics is headquartered in Blue Bell, United States.
What does Seneca Therapeutics do?
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.
What stage is Seneca Therapeutics at?
Seneca Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Seneca Therapeutics — Funding & Investors." VCBacked, August 28, 2025, https://www.vcbacked.co/company/seneca-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2025). Seneca Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/seneca-therapeutics
Wikipedia (cite web)
{{cite web |title=Seneca Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/seneca-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego